|
|
||||||||
1Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, and 2The Graduate School of Biomedical Sciences, University of Texas, Houston, Texas; and 3Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
Submitted 11 May 2007 ; accepted in final form 26 June 2007
Adenosine is generated at sites of tissue injury where it serves to regulate inflammation and damage. Adenosine signaling has been implicated in the regulation of pulmonary inflammation and damage in diseases such as asthma and chronic obstructive pulmonary disease; however, the contribution of specific adenosine receptors to key immunoregulatory processes in these diseases is still unclear. Mice deficient in the purine catabolic enzyme adenosine deaminase (ADA) develop pulmonary inflammation and mucous metaplasia in association with adenosine elevations making them a useful model for assessing the contribution of specific adenosine receptors to adenosine-mediated pulmonary disease. Studies suggest that the A2A adenosine receptor (A2AR) functions to limit inflammation and promote tissue protection; however, the contribution of A2AR signaling has not been examined in the ADA-deficient model of adenosine-mediated lung inflammation. The purpose of the current study was to examine the contribution of A2AR signaling to the pulmonary phenotype seen in ADA-deficient mice. This was accomplished by generating ADA/A2AR double knockout mice. Genetic removal of the A2AR from ADA-deficient mice resulted in enhanced inflammation comprised largely of macrophages and neutrophils, mucin production in the bronchial airways, and angiogenesis, relative to that seen in the lungs of ADA-deficient mice with the A2AR. In addition, levels of the chemokines monocyte chemoattractant protein-1 and CXCL1 were elevated, whereas levels of cytokines such as TNF-
and IL-6 were not. There were no compensatory changes in the other adenosine receptors in the lungs of ADA/A2AR double knockout mice. These findings suggest that the A2AR plays a protective role in the ADA-deficient model of pulmonary inflammation.
inflammation; chemokines; asthma; adenosine receptors
This article has been cited by other articles:
![]() |
H. Wang, W. Zhang, C. Zhu, C. Bucher, B. R. Blazar, C. Zhang, J.-F. Chen, J. Linden, C. Wu, and Y. Huo Inactivation of the Adenosine A2A Receptor Protects Apolipoprotein E-Deficient Mice From Atherosclerosis Arterioscler. Thromb. Vasc. Biol., July 1, 2009; 29(7): 1046 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, A. Mohsenin, E. Morschl, H. W. J. Young, J. G. Molina, W. Ma, C.-X. Sun, H. Martinez-Valdez, and M. R. Blackburn Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor J. Immunol., June 15, 2009; 182(12): 8037 - 8046. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fernandez, S. Trzaska, T. Wilder, L. Chiriboga, M. R. Blackburn, B. N. Cronstein, and E. S. L. Chan Pharmacological Blockade of A2A Receptors Prevents Dermal Fibrosis in a Model of Elevated Tissue Adenosine Am. J. Pathol., June 1, 2008; 172(6): 1675 - 1682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |